Stifel Financial Corp Cytokinetics Inc Transaction History

Stifel Financial Corp

$106 Billion
Q3 2025

A detailed history of Stifel Financial Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Stifel Financial Corp holds 44,626 shares of CYTK stock, worth $2.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,626

Previous 17,746 151.47%

Holding current value

$2.96 Million

Previous $586,000 318.43%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$33.23 - $54.96 $893,222 - $1.48 Million	26,880 Added 151.47%	44,626 $2.45 Million
Q2 2025 Aug 14, 2025	SELL	$29.84 - $42.92 $28,885 - $41,546	-968 Reduced 5.17%	17,746 $586,000
Q1 2025 May 13, 2025	SELL	$40.19 - $51.12 $254,362 - $323,538	-6,329 Reduced 25.27%	18,714 $752,000
Q4 2024 Feb 13, 2025	SELL	$46.36 - $58.62 $1,112 - $1,406	-24 Reduced 0.1%	25,043 $1.18 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $100,339 - $117,853	1,959 Added 8.48%	25,067 $1.32 Million

Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $335 - $525	-7 Reduced 0.03%	23,108 $1.25 Million
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $510 - $864	8 Added 0.03%	23,115 $1.62 Million
Q4 2023 Feb 12, 2024	SELL	$26.88 - $83.49 $12,311 - $38,238	-458 Reduced 1.94%	23,107 $1.93 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $62,219 - $77,320	-2,112 Reduced 8.23%	23,565 $694,000
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1,500 - $1,874	46 Added 0.18%	25,677 $837,000
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $17,413 - $23,860	522 Added 2.08%	25,631 $901,000
Q4 2022 Feb 13, 2023	SELL	$35.77 - $51.11 $71,754 - $102,526	-2,006 Reduced 7.4%	25,109 $1.15 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $5,241 - $7,414	-136 Reduced 0.5%	27,115 $1.31 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $36,169 - $52,148	-1,066 Reduced 3.76%	27,251 $1.07 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $4,520 - $6,992	-152 Reduced 0.53%	28,317 $1.04 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $61,108 - $82,510	-1,779 Reduced 5.88%	28,469 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $131,930 - $254,325	7,116 Added 30.76%	30,248 $1.08 Million
Q2 2021 Aug 13, 2021	BUY	$19.79 - $26.99 $217 - $296	11 Added 0.05%	23,132 $458,000
Q1 2021 May 14, 2021	BUY	$18.57 - $25.68 $160,834 - $222,414	8,661 Added 59.9%	23,121 $538,000
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $37,127 - $69,608	2,433 Added 20.23%	14,460 $301,000
Q3 2020 Nov 16, 2020	SELL	$20.58 - $28.96 $15,208 - $21,401	-739 Reduced 5.79%	12,027 $260,000
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $142,340 - $314,554	12,766 New	12,766 $301,000

Others Institutions Holding CYTK

# of Institutions

446

Shares Held

129M

Call Options Held

5.25M

Put Options Held

1.18M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $6.25B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Cytokinetics Inc Transaction History